Please login to the form below

Not currently logged in
Email:
Password:

Damian Eade to lead Insight Research Group's new digital team

New business team will focus on mobile, strategy and new channels

Insight Research Group Damien EadeInsight Research Group has appointed its research director Damian Eade to lead a new digital business team.

The UK-based agency's new team will focus on mobile developments, digital strategies and helping pharma and healthcare clients embrace new digital channels.

Eade said: “Digital has moved from 'experimental' to something that pharmaceutical companies are having to now incorporate as a matter of course. We aren't just dealing with 'early adopters' dipping a toe in the water anymore.

“Digital has now gained greater recognition and become a dedicated part of the marketing mix, but this is still new territory for many of our clients.”

Insight's new digital business team has broad experience in digital research, which covers tactical implementation of, and transition to, tablet-based campaigns as well as research to help clients understand useage, behaviours and needs amongst healthcare professionals.

15th May 2013

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

For over a decade, our medical communication services have helped pharmaceutical companies optimize their brand, disease and corporate objectives. Building...

Latest intelligence

Precision paediatrics: Treating patients with CAR-T
Dr Stuart Adams specialises in using T-cell therapy to treat paediatric patients at Great Ormond Street Hospital. Here, he explains what it was like to develop and deliver a groundbreaking...
What does it mean to be an agile organisation
We spoke with Philip Atkinson to learn how healthcare and pharmaceutical companies can rapidly respond to changes in the market....
Battling breast cancer with precision medicine (Part 2)
Dr Mark Moasser treated breast cancer survivor Laura Holmes-Haddad (interviewed in part one) with an innovative precision medicine, which at the time was yet to be approved. Here he gives...

Infographics